GABELLI FUNDS LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 47 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$3,758,000
+2.6%
3,792,0000.0%0.02%
-4.0%
Q1 2021$3,662,000
+2.2%
3,792,0000.0%0.02%
-3.8%
Q4 2020$3,583,000
+2.6%
3,792,0000.0%0.03%
-3.7%
Q3 2020$3,493,000
+4.7%
3,792,0000.0%0.03%0.0%
Q2 2020$3,337,000
+9.6%
3,792,0000.0%0.03%0.0%
Q1 2020$3,045,000
-11.3%
3,792,0000.0%0.03%
+22.7%
Q4 2019$3,432,000
+12.6%
3,792,000
+15.2%
0.02%
+10.0%
Q3 2019$3,049,000
-30.6%
3,292,000
-26.8%
0.02%
-28.6%
Q2 2019$4,391,0004,500,0000.03%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders